Tretinoin and Thiotepa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tretinoin (tretinoin) and Thiotepa (thiotepa). Common drug interactions include leukaemia recurrent among females.

The phase IV clinical study analyzes what interactions people have when they take Tretinoin and Thiotepa. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Tretinoin?

Tretinoin has active ingredients of tretinoin. It is often used in acne. eHealthMe is studying from 6,479 Tretinoin users. Check the latest studies of Tretinoin.

What is Thiotepa?

Thiotepa has active ingredients of thiotepa. eHealthMe is studying from 8,097 Thiotepa users. Check the latest studies of Thiotepa.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

14 people who take Tretinoin and Thiotepa together, and have interactions are studied.

Tretinoin and Thiotepa drug interactions.

What are the common drug interactions of Tretinoin and Thiotepa, by gender? *:

female:

Leukaemia recurrent (repeat cancer of bone marrow or blood cells)
Lower respiratory tract infection fungal
Staphylococcal infection (an infection with staphylococcus bacteria)
Stem cell transplant
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
Malaise (a feeling of general discomfort or uneasiness)
Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
Chronic graft versus host disease in skin (damage by immune cells to skin after grafting)
Headache (pain in head)
Hypersensitivity

male:

n/a

What are the common drug interactions of Tretinoin and Thiotepa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Malaise (a feeling of general discomfort or uneasiness)
Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
Stem cell transplant
Leukaemia recurrent (repeat cancer of bone marrow or blood cells)
Lower respiratory tract infection fungal

40-49:

n/a

50-59:

Chronic graft versus host disease in skin (damage by immune cells to skin after grafting)
Headache (pain in head)
Hypersensitivity
Neutropenia (an abnormally low number of neutrophils)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Staphylococcal infection (an infection with staphylococcus bacteria)
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)

60+:

n/a

What are the existing conditions these people have? *

Acute Promyelocytic Leukaemia (cancer of the blood and bone marrow): 12 people, 85.71%
Bone Marrow Conditioning Regimen: 8 people, 57.14%
Leukaemia Recurrent (repeat cancer of bone marrow or blood cells): 2 people, 14.29%
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 1 person, 7.14%
Neoplasm Malignant (cancer tumour): 1 person, 7.14%
Leukopenia (less number of white blood cells in blood): 1 person, 7.14%
Infection: 1 person, 7.14%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 7.14%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Tretinoin and Thiotepa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously